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ABSTRACT
Aims To report the global uptake of simple limbal 
epithelial transplantation (SLET) and compare the 
economic, clinical and social outcomes of SLET with 
those of cultured limbal epithelial transplantation (CLET).
Methods A comprehensive literature review and 
an online survey of eye surgeons were conducted to 
understand the efficacy and current uptake of SLET 
surgery. A de novo economic model was developed to 
estimate the cost savings with SLET compared with 
CLET. Our economic analysis is conducted from an Indian 
perspective, as this is where the technique originated. A 
scenario analysis using the UK cost data and a user- 
friendly Excel model is included to allow users to input 
the costs from their setting to estimate the cost savings 
with using SLET compared with using CLET
Results The anatomical success with SLET in adults 
(72.6% (range 62%–80%)) was the same as CLET 
(70.4% (range 68%–80.9%)). For children, the outcome 
for SLET (77.8% (range 73%–83%)) was better than 
with CLET (44.5% (range 43%–45%)). In response to 
our informal questionnaire, 99 surgeons reported to 
have performed SLET on 1174 patients in total. They 
appreciated that SLET negates the requirement for costly 
tissue engineering facilities. Results of economic analysis 
suggested that SLET provided an estimated cost- savings 
of US$6470.88 for adults and US$6673.10 for children. 
In broad terms, the cost of SLET is approximately 10% of 
the cost of CLET for adults and 8% for children.
Conclusion SLET offers a more accessible and 
financially attractive alternative to CLET to treat limbal 
stem cell deficiency.
INTRODUCTION
Limbal epithelial stem cells play a critical role in 
preserving the health of the corneal epithelium. In 
addition to refreshing the cells, they act as a barrier 
to prevent conjunctivalisation and vascularisation 
of the cornea that may result in loss of clarity. 
Damage or loss of these epithelial cells can thus 
lead to potentially severe visual impairment due 
to a condition termed limbal stem cell deficiency 
(LSCD).1 2
Cultivated limbal epithelial transplantation 
(CLET) is a procedure of transplanting autologous 
laboratory- expanded limbal epithelial stem cells to 
replace conjuctivalised cornea with cultured epithe-
lial cells. After 2–3 weeks of cell expansion, the 
cultured cells are transplanted onto the patient’s 
affected eye, most commonly using human donor 
amniotic membrane which often integrates into the 
corneal stroma without completely disappearing 
leaving the cultured cells attached to the underlying 
corneal stroma. Recently, a fibrin scaffold has been 
used for the delivery of cultured cells.3
CLET has an impressive success rate, however, it 
requires highly specialised tissue culture expertise 
and Good Manufacturing Practice facilities for the 
ex vivo expansion of the cells incurring significant 
costs for establishing specialist facilities/equipment, 
consumables and highly skilled labour. These facil-
ities used for ex vivo expansion of cells must also 
operate under a strict set of regulations that require 
considerable ongoing investment. It is also a two- 
stage procedure, wherein after retrieving the donor 
cells from the patient, cells are expanded over 2–3 
weeks in the laboratory after which they are trans-
planted to the affected eye.
In 2012, a novel procedure termed simple limbal 
epithelial transplantation (SLET) was proposed 
for patients with LSCD, where small pieces of 
tissue from the limbus of the healthy eye of the 
patient are directly transplanted into the affected 
eye, after surgically removing abnormal tissue, in 
a single surgery.4 SLET still needs the use of amni-
otic membrane to support the cell outgrowth from 
the pieces of limbal tissue but does not require 
any ex vivo tissue expansion nor a second surgery. 
Several SLET training workshops have now been 
conducted both in India and internationally, and as 
a result, SLET is now beginning to be used around 
the world.
It is suggested that SLET can overcome the chal-
lenges of establishing CLET and reach more patients 
as it does not require regulatory approval related to 
ex vivo expansion of cells and only requires a single 
surgery (compared with two surgeries in CLET) 
alleviating demands on the healthcare system 
and the patient. However, to our knowledge, no 
study has comprehensively estimated the clinical, 
economic and social impact of using SLET versus 
CLET for patients with LSCD.
The aim of this study is to estimate and report 
the economic, clinical and social impact of SLET in 
comparison with CLET.
MATERIALS AND METHODS
A multidisciplinary approach using mixed methods 
was used to estimate the clinical, economic and 
social impact of using SLET versus CLET for 
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to the efficacy and current uptake of SLET surgery around the 
world; the economic impact relates to the costs associated with 
both procedures, and the social impact relates to the benefits to 
the patients and the healthcare system.
Methods for the estimation of clinical impact
Literature review
A literature review using search terms related to SLET in 
PubMed and Cochrane Library was conducted in May 2020 by 
two researchers (AS and VijayS) working independently to mini-
mise the possibility of relevant studies being missed. From the 
studies identified in the review, data on the clinical effectiveness 
of SLET, the country/setting and the number of patients treated 
with SLET were extracted. To compare the clinical outcomes, we 
purposefully selected clinical studies with at least 30 patients and 
at least 1 or more years follow- up (table 1).
Questionnaire-based survey
In addition to surveying the published peer- reviewed litera-
ture, we obtained institutional permission to survey surgeons 
concerning their use of SLET (Ethics ref no LEC BHR- P-04-
20-414). An iterative process was used in developing the set of 
questions regarding the surgeons’ country/setting, the number 
of years of experience of conducting eye surgery, experience 
with SLET and CLET, availability of cell culture facilities and 
their opinions on SLET. The questionnaire was converted into 
an online survey specifically to target surgeons who attended 
a SLET workshop in recent years. The data gathered from the 
survey were collated and analysed to understand the uptake of 
SLET.
Estimation of the economic impact
Pathways of both surgeries were developed, and bottom- up 
costing was used to populate a de novo economic model to esti-
mate the total costs of each procedure from a healthcare system 
perspective.
An iterative approach using process mapping techniques was 
used to understand the pathways involved in SLET and CLET. 
First, draft pathways were specified, based on the findings of the 
literature review, by researchers with knowledge of SLET and 
CLET. These were presented to clinical experts for feedback, 
and a final list of steps associated with SLET and CLET was put 
together (figure 3). A brief description of each of the steps was 
also presented to the clinicians to ensure the validity of resource 
use and costs associated with each step.
The total costs for SLET and CLET were estimated using 
bottom- up costing that is, by capturing and aggregating the costs 
associated with each of the steps. The costs were estimated from 
an Indian perspective, using the costs from the LV Prasad Eye 
Institute (LVPEI), Hyderabad, India for the base case analyses. A 
de novo economic model was developed in Microsoft Excel to 
estimate the total costs associated with SLET and CLET. Uncer-
tainty in the costs was captured using parametric distributions 
and probabilistic sensitivity analyses were performed to estimate 
the robustness of the total cost estimates. Scenario analyses were 
also performed using costs from India and UK.
Estimation of the social impact
To understand the health system impact of SLET surgery 
compared with CLET, the lead clinicians involved in this study 
were interviewed and we also solicited comments, both good 
and bad, from surgeons who responded to our questionnaire.
RESULTS
Clinical impact of LSCD
Literature review
The literature searches identified 83 studies in which SLET 
outcomes were measured. After screening at the title and abstract 
level, 79 articles remained and of these 30 articles remained 
after a full- text examination. The Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses diagram is presented 
in figure 1. An overview of the included studies and the data 
extracted is presented in online supplemental appendix 1.
The review identified 30 studies,4–33 covering 8 countries and 
a total of 432 patients reported as receiving SLET. The median 
follow- up in the largest case series (125 cases, Basu et al) was 
1.5 years (range 1–4 years)13 and the longest reported follow- up 
period was 4.9 years.17 The number of patients who received 
SLET surgery estimated from the questionnaire is 1315 which is 
much higher than those reported in the peer- reviewed literature 
as expected. The cumulative number of published studies and 
patients treated with SLET are shown in figure 2A,B, respectively.
The clinical outcome of SLET/CLET is reported as anatomical 
success which refers to re- establishment of a completely epithe-
lised, stable and avascular corneal surface and functional success 
which refers to improvement in best- corrected visual acuity of 
two- lines or greater.34 Anatomical and functional success in 
six studies of CLET and four studies of SLET, which involved 
at least 30 patients with a clinical follow- up of at least 1 year, 
is summarised in table 1. The mean anatomic success of cases 
Table 1 Clinical outcomes of cultured limbal epithelial transplantation and simple limbal epithelial transplantation
Author Year Country N Anatomic success (%) Functional success (%) Mean follow- up in years (range)
Cultured limbal epithelial transplantation outcomes
  Rama et al40 2010 Italy 107 68 54 2.9 (1–9.4)
  Paulkin et al41 2010 Italy 30 77 73 2.4 (0.8–6)
  Sangwan et al4 2011 India 200 71.4 60.3 3 (1–7.6)
  Sejpal et al35 2012 India 107 37 NA 3.4 (1–9.8)
  Ganger et al36 2015 India 54 72 23 1.8 (0.3–3.3)
  Fasolo et al42 2017 Italy 59 42 NA 6 (1–13)
Simple limbal epithelial transplantation outcomes
  Basu et al13 2016 India 125 76 75 1.5 (1–4)
  Vazirani et al17 2016 Multicentre 68 84 65 1 (0.5–4.9)
  Gupta et al23 2018 India 30 70 50 1.1 (0.5–3.4)
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was 78% (range 76%–84%) and the mean functional success of 
cases was 68.6% (range 50%–75%) which demonstrated clinical 
equivalence to CLET which has been reported to have anatomic 
success in 61.4% cases (range 37%–77%) and functional success 
in 51.5% cases (range 17%–70%).34 Four studies reported a 
greater clinical benefit of using SLET instead of CLET when 
assessing outcomes for paediatric patients.5 13 14 24
Questionnaire survey
Out of the 294 members of the Ocular Surface group 
of ophthalmologists (http://www. corneasociety. org), 99 
belonging to different institutes, hospitals and individual 
clinics responded to this questionnaire. As SLET was discov-
ered in India and most of the SLET workshops/Wet- labs/
Training Courses were conducted in India, the majority of 
the surgeons were from India (91) but we also had the partic-
ipation of surgeons from the USA (1), Mexico (3), Oman (1), 
Austria (1), Colombia (1), and Greece (1).
Of these 87% of surgeons had undertaken SLET surgery 
for the treatment of 1174 patients with LSCD, with 29% of 
surgeons undertaking the surgery in less than 5 patients, 35% in 
5–10 patients, 32% in 11–50 patients and 2% with experience 
of SLET in more than 50 patients.
In response to the clinical experience of SLET, 1% surgeons 
were unhappy, 56% reasonably happy and 43% were very happy 
with the SLET procedure. Surgeon’s comments regarding their 
experience with SLET were that the procedure is convenient, 
easy, cost- effective, scientific, efficient, reliable and reproduc-
ible. A few surgeons stated that there is a learning curve for SLET 
and there are issues of acceptance, vascularisation from the edges 
and unusual responses in paediatric cases. The detailed analysis 
of the results from the questionnaire- based survey is shown in 
online supplemental appendix 2.
Economic analysis
A brief description of the steps involved in SLET and CLET is 
presented in figure 3, and a summary of the costs is presented in 
table 2, and these are described in more detail in online supple-
mental appendix 3.
Cost data
The costs in Indian rupee (INR) associated with each of the steps 
involved in SLET and CLET established in the running of one 
large Indian hospital are presented in table 2 and described in 
detail in online supplemental appendix 3. The costs from a UK 
perspective are also presented as a scenario analysis.
Costs of SLET versus CLET
The total cost savings are provided as a breakdown of the indi-
vidual cost differences as shown in table 3. The costs of SLET 
are approximately 10% of the costs of CLET for adults and 8% 
of the costs of CLET for children, with SLET providing an esti-
mated cost savings of INR 480 000 for adults and INR 495 000 
for children.
A comparison of the total costs of SLET versus CLET is also 
presented in figure 4A,B, for adults and children, respectively. 
Most of the savings associated with SLET are due to a reduction 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses diagram for the simple limbal epithelial transplantation literature 
review.
Figure 2 Publication pattern of SLET studies over the years 
2012–2019. (A) Number of published papers over years. (B) Number 
of patients treated with SLET estimated from published studies. SLET, 














































































































4 Thokala P, et al. Br J Ophthalmol 2021;0:1–6. doi:10.1136/bjophthalmol-2020-318642
Clinical science
in the need for cell culturing and the second surgery required 
for CLET. For children, the cost savings are higher due to the 
additional reduction in the anaesthesia costs.
Costs of surgery and cell culture were identified as the key cost 
drivers, the lower the costs of cell culture and surgery the lower 
the cost savings. Similarly, the higher the costs of cell culture 
and surgery the higher the average cost savings. This suggests 
that the cost savings are likely to be greater in developed coun-
tries where the costs associated with cell culture and surgery 
are higher. This is explored as a scenario analysis using the UK 
costs, which demonstrated cost savings of £54 061 for each adult 
patient (approximately INR 5 million using an exchange rate 
of 1 GBP=INR 94 from  xe. com), as reported in online supple-
mental file 2.
Social impact
Interviews with the two clinicians involved in this study high-
lighted several benefits associated with SLET such as low- cost 
procedure, requirement of single surgery can be performed in 
simple clinical setting and lower risk of contamination. The 
details are given in online supplemental appendix 4.
DISCUSSION
Peer- reviewed studies provide evidence from several groups 
that SLET has comparable clinical efficacy to CLET for adults 
and is slightly better for children.24The anatomical success with 
SLET in adults is 72.6% (range 62%–80%) and in children is 
77.8% (range 73%–83%).13 24 For CLET, the anatomical success 
in adults is 70.4% (range 68%–80.9%) and in children is 44.5 
(range 43%–45%).35 36
The figures from the recent reviews of the two techniques 
suggest that the number of patients that have been treated over 
nearly 20 years by CLET is comparable to those treated with 
SLET in just over 7 years.34 37–39 The numbers from our informal 
survey suggest that the number of SLET surgeries has crossed the 
1000 mark which, as expected, is higher than estimates from the 
published literature.
Our analyses suggest that SLET surgery is a cost- saving 
strategy when implemented for the care of patients with LSCD. 
A specialist eye hospital such as LVPEI is estimated to treat 
approximately 85 patients each year, and the estimated cost 
saving for replacement of CLET with SLET in such a hospital is 
Figure 3 Flow chart of steps and procedures in CLET and SLET. CLET, 
cultured limbal epithelial transplantation; SLET, simple limbal epithelial 
transplantation.




Range (lower 95% CI 
to upper 95% CI)
Costs associated with CLET
  First CLET surgery (biopsy) 34 800 10 300 to 86 700
  General anaesthesia* 3600 2400 to 9300
  Hospital stay* 3000 per day 1200 to 11 000
  Amniotic membrane 2500 –
  Cell culture 437 500 350 000 to 5 25 000
  Second CLET surgery (transplantation) 34 800 10 300 to 86 700
  Hospital stay* 3000 per day 1200 to 11 000
  General anaesthesia* 3600 2400 to 9300
  Fibrin glue 5900 1800 to 14 600
Costs associated with SLET
  Amniotic membrane 2500 –
  Single SLET surgery 34 800 10 300 to 86 700
  Hospital stay* 3000 per day 1200 to 11 000
  General anaesthesia* 3600 2400 to 9300
  Fibrin glue 5900 1800 to 14 600
*Only for children.
CLET, cultured limbal epithelial transplantation; INR, Indian rupee; SLET, simple 
limbal epithelial transplantation.
Table 3 Breakdown of cost results in Indian rupees (INR), with 









































*Using an exchange rate of US$1=INR 75, from xe.com.
Figure 4 Graph showing the cost details of performing CLET and 
SLET in Indian rupees. (A) Cost for adults. (B) Cost for children. CLET, 
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therefore around INR 40 million per annum. We have provided 
a user- friendly Excel tool for the readers to input costs related to 
their setting to estimate the economic impact of SLET compared 
with CLET.
The results of the current analysis have important implications 
for eye hospitals facing rising demand. The evidence suggests 
that the use of SLET may substantially reduce the number of 
surgeries which may also alleviate pressure on beds and asso-
ciated costs. Indeed, SLET has replaced CLET as the preferred 
surgery option for patients with LSCD and several other hospi-
tals around the world have now established SLET.
We present a strong case for SLET likely to be more commonly 
adopted in the future due to issues associated with CLET such as 
difficulty in setting up cell culture facilities, lack of commercial 
cell culture services, the prohibitive cost of cell culture and the 
many advantages offered by SLET.
To culture cells to a standard required for regulatory approval 
requires highly trained cell culture staff specialised premises and 
an invisible, but real burden of keeping these funded and regula-
tory compliant year on year. All such ventures begin with research 
funding and indeed quite successful clinically, however, there 
are very few cases where these endeavours become adopted as a 
routine clinical service with the full cost. To the best of our knowl-
edge, there is currently only one organisation providing laboratory 
expansion of autologous limbal epithelial cells as a commercial 
clinical service (Chiesi Farmaceutica of Palermo, Italy). In 2015, 
they received European Medicines Agency approval for their 
autologous cell therapy Holoclar (the first stem cell product to be 
approved in European Union), where laboratory- expanded autol-
ogous cells are grown and delivered to the patient on a fibrin mat.3 
In 2018, The National Institute of Health and Care Excellence 
(NICE) in England and Wales gave provisional approval for the use 
of Holoclar based on a confidential discount, as it was acknowl-
edged that there was no other commercially approved method-
ology for culturing corneal cells in the UK for clinical use (https://
www. nice. org. uk/ guidance/ ta467/ chapter/ 5- Implementation).
Even when the service is set up to take on the culture of cells 
for clinical use, the economics of doing this meant that cost of 
each cell culture is prohibitive. Our costing model (online supple-
mental file 2)highlights the substantial costs of cell culturing (many 
times higher than the cost of the surgery itself). We were unable to 
find any such published figures in the UK or Europe, except for 
Holoclar as described above, where the price for culture service 
is listed as £80 000 per eye. Provisional approval by NICE is at 
a confidential discount price (at a discount not disclosed) on the 
understanding that long- term follow- up studies are required to be 
published when available. At the time of writing, we have not been 
able to find any information on the numbers of patients treated 
using this approach.
On the contrary, introduction of in situ cornea regeneration on 
the cornea offered by SLET is immediately attractive in economic 
terms. It can be done in institutes that do not have access to facil-
ities for cell culture and surgeons can be trained to undertake the 
SLET procedure in less than a week (and then in turn to pass on 
the training). From the patient’s perspective, there is one rather 
than two surgeries so less time to be spent in hospital, and a factor 
of 8- fold/10- fold savings in the costs of undertaking SLET versus 
CLET.
CONCLUSIONS
The published clinical data suggest that SLET is advantageous 
over CLET. The economic argument for using SLET rather than 
CLET is demonstrated in this study in a way that other centres 
can access it and run their analysis. In summary, simplification of 
SLET technique so that cells slowly grow out of the small tissue 
explants to form a new cornea offers a viable, financially attractive 
and much more accessible approach to treat loss of vision.
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Appendix 2: Responses from the SLET survey questionnaire 
 
In addition to surveying the published peer-reviewed literature we obtained institutional 
permission (Clinical, economic and social impact of Simple limbal epithelial 
transplantation [SLET] vs Cultivated limbal epithelial transplantation [CLET]- 
DrSayanBasu, DrVivek Singh- Ethics Ref No LEC BHR-P-04-20-414) to undertake   
questionnaires of surgeons concerning their use of SLET.The details of the 
questionnaire can be found in Appendix 1.The questionnaire was converted to an online 
format using Google form and the link was sent to The Ocular Surface group of 
ophthalmologists. 
 
Out of the 294 members of The Ocular Surface group of ophthalmologists, 99members 
belonging to different institutes,hospitals andindividual clinics responded to this 
questionnaire.  As SLET was conceptualized in India and most of the SLET workshops/ 
wet-lab/ training courses were conducted in India,themajority of the surgeons who 
participated in the survey were from India (91), however we also had participation of 
surgeons from USA (1), Mexico (3), Oman (1), Austria (1), Colombia (1), and Greece 
(1). Out of these 99 surgeons, 81% were happy to share their contact details(Fig 1A). 
 
More than 78% of these surgeons had participated in SLET workshops/ Wet-lab/ 
Training Courses conducted by surgeons specialized in theSLET procedure (Fig 1B).  
The number of participants in ocular surface workshops was constant in the initial years 
of SLET inception (2012 to 2014) with a slight increase seen thereafter till 2016 and 
peaking observed in 2018 (Fig 1C).  
 
Of these 87%surgeons had undertaken SLET surgery for treatment of 1174 LSCD 
patients(Fig 1D). The responses were further categorized based on the number of 
surgeries. 29% of surgeons hadundertaken the surgery in less than 5 patients, 35% in 5 
to 10 patients, 32% in11 to 50 patients and only 2% had experience of SLET in more 
than 50 patients (Fig 1E).  
 
In response to the clinical experience of SLET, 1%were unhappy, 56% reasonably 
happy and 42% were very happy with the SLET procedure (Fig 1F).Surgeons 
comments regarding their experience with SLET were that the procedure is convenient, 
easy, cost effective, scientific, efficient, reliable and reproducible. Afew surgeons stated 
that there is a learning curve for SLET and there are issues of graft acceptance, 
vascularization from the edges post surgery and unusual responses in pediatric cases. 
More than 50% of surgeons had undertaken other procedures such as CLAU and CLET 
for treatment of LSCD (Fig 1G). CLAU was practiced by 36% of surgeons, both CLET 
and CLAU by 10% of the surgeons and CLET by only 5% of surgeons due to the fact 
that only 5%of surgeons had cell culture facilities for CLET (Fig 1H). A total of 77 and 
809 LSCD patients were treated using CLET and CLAU respectively (Fig 1I). In 
response to if they were given a choice of SLET or CLET 100% of these surgeons 
responded that they would prefer SLET.  
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Appendix 3: Costs of SLET and CLET Pathways 
Cost data from LVPEI, Hyderabad, India 
The costs for India were estimated from the actual tariff costs of the different steps identified 
from the LVPEI costing database. Because of the mission of L V Prasad Eye Institute (LVPEI) to 
provide equitable and quality eye care to all sections of society (www.lvpei.org), around 50% of 
its services are provided free and fee-paying patients can choose between six categories of 
service as listed in the Table below.  
There is no difference in the surgical procedures offered between these categories, but there is 
a difference in the provision of the associated non-surgical facilities such as the quality of 
hospital accommodation (please see the discussion for further details). For the base case 
deterministic analysis, we used the “Private” tariff but the least expensive the “Economy” and 
the most expensive the “Exclusive” were used to specify the lower and upper bounds for 
parametric distributions. 
Supplementary table 2: Price schedule for fee-paying patients at LVPEI (in Indian 
Rupees) 
Procedure name Economy   
Semi-
Private 
Private  Deluxe  Premium Exclusive 
Amniotic Membrane Graft 
Large 
10300 17100 34800 53400 53400 86700 
Limbal Biopsy 10300 17100 34800 53400 53400 86700 
Limbal Transplantation 11700 19400 38900 58500 58500 98300 
Stem Cell Transplant 18500 30700 63200 97400 97400 156000 
Fibrin Glue 1800 2900 5900 8200 8200 14600 
Simple Limbal Epithelial 
Transplant 
19200 31900 67200 100200 100200 161700 
General Anesthesia 1 - 
15 Minutes 
2400 3600 3600 3600 3600 9300 
General Anesthesia 31 - 
60 Minutes 
4700 8200 8200 8200 8200 11600 
Room Rent Per Day 1200 2000 3000 4000 4000 11000 
 
Costs for patients receiving CLET   
Stay in hospital   
For adults receiving CLET, a local anaesthetic is used for the procedure and patients can leave 
hospital on the same day. As such, we assumed that there is no hospital stay for adults. For 
children, however, a general anaesthetic needs to be used which requires 1 to 3 days of 
overnight stay, at a cost of INR 3000 per day (range INR 1200 to INR 11000). Therefore, 
separate analyses were performed for adults and children. 
First Surgery for CLET 
At this first surgery, a small section of the limbus is taken for the laboratory expansion of cells. 
This is done under local anaesthetic for adults (included in surgery costs) and general 
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anaesthetic for children (mean INR 3600 with a range of INR 2400 to INR 9300). The procedure 
generally takes less than 30 minutes and the adult patients are discharged from hospital on the 
same day while the children need hospital stay (see above). The mean costs of this surgery are 
INR 34,800 with a range of INR 10,300 to INR 86,700. All patients are requested to return when 
the cells are ready for transplantation, typically two to three weeks later. They are also seen 
next for a follow up visit, if admitted or not. 
Use of amniotic membrane   
The amniotic membrane is used as a substrate on which to grow the cells from the limbal biopsy 
in the laboratory. This is sourced from a tissue bank run to international standards in LVPEI. 
While human tissue is donated for free clinical use, tissue banks charge a cost to cover the 
processing and storage of the tissues to help recoup the costs of running the bank. The 
processing costs associated with the tissue bank used by LVPEI is estimated as INR 2500. 
Laboratory expansion of cells  
In the case of CLET, cells are expanded on the amniotic membrane prior to transplantation to 
the eye. The time taken to expand a single biopsy ready for clinical use averages from two to 
three weeks. Using the daily costs associated with cell culturing of INR 25000 and assuming 
17.5 days of cell culture (i.e. average of 2 to 3 weeks), the mean costs were estimated as INR 
437,500 with a range of INR 350,000 (estimated assuming 2 weeks) and INR 525,000 
(estimated assuming 3 weeks). 
Second Surgery for CLET 
At this second surgery, the cells that underwent laboratory expansion are transplanted back into 
the patient’s eye after removal of the scar tissue. This is done under local anaesthetic for adults 
(included in the surgical cost) and general anaesthetic for children (mean INR 8200, range INR 
4700 to 11600). The amniotic membrane is held in place with fibrin glue (mean INR 5900, range 
INR 1800 to INR 14600). A bandage contact lens is applied over the cultured cells at the end of 
procedure. The mean costs of this surgery are INR 34800 with a range of INR 10300 to INR 
86700. 
Stay in hospital   
This is generally not required for adults where a local anaesthetic is used for the procedure. For 
children, however, a general anaesthetic needs to be used which is associated with overnight 
stays of 1 to 3 nights (at a cost of 3000 per day, range 1200 to 11000). 
Costs for patients receiving SLET   
Stay in hospital   
This is not generally required for adults. For children, however, a general anaesthetic needs to 
be used which requires 1 to 3 days of overnight stays (at a cost of INR 3000 per day, range INR 
1200 to INR 11000). As such, separate analyses were performed for adults and children.  
Use of amniotic membrane  
The amniotic membrane used is the same as for CLET, which is sourced from a tissue bank run 
to international standards, and the processing costs associated with the tissue bank used by 
LVPEI is estimated as INR 2500. When used in SLET the membrane provides a biodegradable 
substrate which is placed on the denuded eye held in place with fibrin glue. 
SLET Surgery 
At this surgery, the scar tissue from the affected eye is removed and a small piece of tissue 
from the healthy eye (1-2 mm) is taken and cut into approximately eight pieces. An amniotic 
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membrane is placed over the denuded eye and held in place with fibrin (as above)  and then the 
pieces of corneal explant are placed on the membrane and held in place with a very small 
amount of fibrin glue and a bandage contact lens is placed over these. The costs of amniotic 
membrane and the fibrin glue are the same as for CLET.  
This is done under local anaesthetic for adults (costs included in the surgery) and general 
anaesthetic for children (mean INR 8200, range 4700 to 11600). The procedure generally takes 
30 minutes and the mean costs associated with the surgery are INR 34800, and a range of INR 
10300 to INR 86700. Adult patients are discharged from hospital on the same day while the 
children need a hospital stay (see above).  
Supplementary table 3: SLET cost data from Dr. Shroff's Charity Eye 
Hospital, New Delhi, India 
Item 
Most likely 





Costs associated with SLET 
Amniotic membrane ₹ 2,500 ₹ 2,400 ₹ 2,600 
Single SLET Surgery  ₹ 50,500 ₹ 25,500 ₹ 120,500 
Fibrin Glue ₹ 10,000 ₹ 9,900 ₹ 10,100 
Bandage contact lens ₹ 2,300 ₹ 2,200 ₹ 4,500 
General anaesthesia*  ₹ 5,000 ₹ 4,900 ₹ 5,100 
Hospital stay (in days)* 2 1 3 
Hospital costs per day* ₹ 3,000 ₹ 1,500 ₹ 6,000 
*Only for children  
 










Costs associated with CLET 
First CLET Surgery 
(biopsy) 
£864 £750 £950 
Minor, Cornea or Sclera 
Procedure for Biopsy; Day case 
BZ65Z 
General anaesthesia* £220 £150 £334 
Assumed to two thirds as much 
as private costs  
Hospital stay (in 
days)* 
2 1 3 
Assumption 
Hospital costs per 
day* 
£340 £300 £380 
Daily bed cost of excess stay 
with Very Complex, Cornea or 
Sclera Procedures with CC Score 
0-1  BZ61B 
Amniotic membrane £220 £180 £250 
Frozen Amniotic Membrane 
2x2cm NHS Blood and 
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Transplant 
Cell culture £50,000 £30,000 £80,000 Holoclar 
Second CLET Surgery 
(transplantation) 
£3,099 £2,600 £3,500 
Very Complex, Cornea or Sclera 
Procedures with CC Score 0-1, 
Elective BZ60B  
Fibrin Glue £10 £8 £12  Assumption 
Bandage contact lens £4 £3 £5 
Bandage contact lens applied by 
opthamologist 
General anaesthesia*  £220 £150 £334 
Assumed to two thirds as much 
as private costs  
Hospital stay (in 
days)* 
2 1 3 
Assumption 
Hospital costs per 
day* 
£340 £300 £380 
Daily bed cost of excess stay 
with Very Complex, Cornea or 
Sclera Procedures with CC Score 
0-1  BZ61B 
Costs associated with SLET 
Amniotic membrane £220 £180 £250 
Frozen Amniotic Membrane 
2x2cm NHS Blood and 
Transplant 
Single SLET Surgery  £3,099 £2,600 £3,500 
Very Complex, Cornea or Sclera 
Procedures with CC Score 0-1, 
Elective BZ60B  
Fibrin Glue £10 £8 £12  Assumption 
Bandage contact lens £4 £3 £5 
Bandage contact lens applied by 
opthamologist 
General anaesthesia*  £220 £150 £334 
Assumed to two thirds as much 
as private costs  
Hospital stay (in 
days)* 
2 1 3 
Assumption 
Hospital costs per 
day* 
£340 £300 £380 
Daily bed cost of excess stay 
with Very Complex, Cornea or 
Sclera Procedures with CC Score 
0-1  BZ61B 
*Only for children  
 
Results of the economic analysis in UK 
Supplementary table 5: Estimated costs of SLET and CLET in the UK 
  CLET SLET 
Average 
Savings 
Surgery  £3,921  £3,076  -845  
Cell Culture £53,432  £216  -53,216  
Total Costs £57,353  £3,292  -54,061  
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Appendix 4: Social impact of SLET 
The surgeons suggested that SLET negates the requirement for costly tissue 
engineering facilities which means it can be offered by more surgeons who do not have 
access to the specialist laboratories required for the cell-based technique. Hence, it is 
accessible to more patients who have been treated at clinics that would otherwise lack 
the expertise, facilities, and approval necessary for the cell culture treatment. Also, they 
highlighted that SLET requires only a single surgery and is quicker - whereas CLET 
demands a separate biopsy and transplantation, with surgeries that are separated by at 
least two weeks for the cells to be expanded in a laboratory. Furthermore, they 
suggested SLET avoids the risk of contamination associated with ex vivo tissue 
expansion, involving the use of bovine serum.   
 
Less than 10% of surgeons made specific comments about the technique-the most 
common comment was that it was less expensive than the previous CLET technique 
and another comment shared by several was that it was comparatively easy to do .One 
surgeon made the point that they would like to see longer-term follow-up data before 
deciding, which is always a consideration with novel techniques (e.g. the same 
comment was made by NICE about the use of Holoclar) but as Table 1 shows there are 
now studies with up to 2 years follow-up for SLET. 
(https://www.nice.org.uk/guidance/ta467) 
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